Agenda

07:00 – 09:00 Breakfast
Session I
08:50 – 09:00 Welcoming Remarks
09:00 – 10:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

Minh-Duc Ngo, Sabrina Hoa

Randomized Controlled Trial in limited Cutaneous Systemic Sclerosis:  a Systematic Literature Review.

Michele Stanciu, Marie Hudson

Chained to a Diagnosis?

 Michael Aw, Inés Colmegna

Case Report: Parvovirus B19 Associated Large-vessel Vasculitis in an Immunocompromised Patient.

Claire Adams, Brett Thombs

Patient Engagement in Rheumatic Research:  State of the Evidence.

Wen Qi, Say Yan Yuen

Musculoskeletal Ultrasound in Systemic Lupus Erythematosus (SLE): A Scoping Review.

Évelyne Vinet

Overweight and Obesity are Key Modifiable Risk Factors for Adverse Outcomes in Systemic Lupus Erythematosus (SLE) Pregnancies.

At the end of this session, participants will be better able to:

  • Recognize a variety of complex rheumatological entities and manage them.
  • Identify, understand and discuss the nature and results of recent research work done by their peers.
10:30 – 11:00 Break
Session II
11:00 – 12:00

Maladie de Sjögren : de la pathophysiologie au traitement.

Xavier Mariette, MD, PhD

At the end of this session, participants will be better able to:

  • Understand the pathophysiologic mechanisms of Sjögren’s disease.
  • Know the most often used drugs in its treatment.
  • Discover new therapeutic pathways.
12:00 – 13:00 Lunch
Session III
13:00 – 13:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

Évelyne Gendron

Alcohol Consumption is Associated with Spinal Radiographic Progression in Axial Spondyloarthritis.

Laëtitia Michou

Identification de variants génétiques rares dans les formes familiales de la Maladie de Dupuytren.

At the end of this session, participants will be better able to:

  • Recognize a variety of complex rheumatological entities and manage them.
  • Identify, understand and discuss the nature and results of recent research work done by their peers.
13:30 – 14:30

La place de l’arthroplastie dans le traitement des pathologies dégénératives de l’épaule.

Stéphane Pelet, MD, PhD, FRCSC

At the end of this session, participants will be better able to:

  • Recognize the indications for the various types of arthroplasties and refer the right patients at the right time for surgical management.
  • Describe to their patients the potential benefits of reverse total shoulder arthroplasty.
  • Set up appropriate therapeutic measures while awaiting surgical treatment.
Session IV
14:30 – 15:30

Grossesses lupiques

Évelyne Vinet, MD, PhD

At the end of this session, participants will be better able to:

  • Discuss the general principles of pregnancy planning in women with SLE.
  • Choose rheumatologic drugs compatible with pregnancy and lactation.
  • Revise the American College of Rheumatology guidelines on management of reproductive health in patients with SLE.
15:30 – 16:00 Break
16:00 – 17:00 Poster Session

Sophie Hu, Brett Thombs

Differential Item Functioning on the 8-itemPatient Health Questionnaire by Disease Sub-type, Language, Sex and Age among People with Systemic Sclerosis.  A Scleroderma Patient-centered Network (SPIN) Cohort Study.

Cassidy Dal Santo, Brett Thombs

Adaptation and Validation of Measures to Assess Coping with Fatigue in Scleroderma:  Two Scleroderma Patient-centered Intervention Network (SPIN) Cohort Studies.

Elsa-Lynn Nassar, Brett Thombs

Update from a Living Systematic Review of the Prevalence of Mood and Anxiety Disorders and Factors Associated with Symptoms in People with Systemic Sclerosis.

Amy Qi, Inés Colmegna

Hip-hop : A Case of Transient Osteoporosis of Both Hips.

Mathieu Rousseau, Sabrina Hoa.

Le rôle des analyses quantitatives des scans thoraciques dans la prédiction de la progression de la maladie pulmonaire interstitielle légère associée à la sclérodermie.

Sabrina Hoa

Distinct Systemic Sclerosis Phenotypes Related to Race/Ethnicity:  an Opportunity to Personalize Care?

Natasha Leblanc, Arielle Mendel

Antibiotic Prophylaxis during Treatment of ANCA-associated Vasculitis with Rituximab: Data from a Canadian Multicenter Cohort.

Kaitlin Nuechterlein, Évelyne Vinet

Placental Abnormalities in Systemic Lupus Erythematosus (SLE): Novel Markers for Adverse Pregancy Outcomes.
19:00

Dinner & Awards
07:00 – 09:00 Breakfast
Session V
9:00 – 9:30

ORAL PRESENTATIONS OF ORIGINAL RESEARCH WORK AND OF CLINICAL CASES

Marianela Brizio, Inés Colmegna

Systemic Sclerosis Mesenchymal Stromal Cells Exhibit Senescence and Profibrotic Features with Preserved Immunomodulatory and Anti-fibrotic Function.

Olivia Stein , Sasha Bernatsky

The Patient Perspective in Systemic Lupus Erythematosus (SLE) Trials:  A Focus Group Study

At the end of this session, participants will be better able to:

  • Recognize a variety of complex rheumatological entities and manage them.
  • Identify, understand and discuss the nature and results of recent research work done by their peers.
9:30 – 10:30

L’histoire de la déplétion des lymphocytes B dans les maladies auto-immunes : du rituximab aux CAR-T cells.


Xavier Mariette, MD, PhD

À la fin de cette session, les participants sauront mieux :

  • Understand the different roles of B lymphocytes in the pathogenesis of auto-immune diseases.
  • Know the currently used means to deplete B lymphocytes in auto-immune diseases.
  • Discover the effects of bispecific Ab and of CAR-T cells to deplete B lymphocytes in auto-immune diseases.
10:30 – 11:00 Break
Session VI
11:00 – 12:00

Brush and Floss: why oral health matters in rheumatology


Carol Hitchon, MD, FRCPC, MSC

À la fin de cette session, les participants sauront mieux :

  • Review the association between oral health and autoimmune rheumatic diseases.
  • Describe oral mucosal immunology and potential relevance to rheumatoid arthritis (RA).
  • Explain the impact of oral care on the management of rheumatic diseases.
12:00 Closing Remarks